More about

Pediatric Oncology

News
June 05, 2022
2 min read
Save

Ifosfamide more likely to extend survival than topotecan-cyclophosphamide in Ewing sarcoma

Ifosfamide more likely to extend survival than topotecan-cyclophosphamide in Ewing sarcoma

CHICAGO — In what researchers described as the first randomized controlled trial of chemotherapy in relapsed or refractory Ewing sarcoma, high-dose ifosfamide proved more effective in extending survival than topotecan and cyclophosphamide.

News
June 04, 2022
3 min read
Save

Innovation can address ‘profound inequality’ in cancer care, ASCO keynote speaker says

Innovation can address ‘profound inequality’ in cancer care, ASCO keynote speaker says

CHICAGO — The keynote speaker at ASCO Annual Meeting urged attendees to focus on social and organizational innovations that can advance equity in cancer care.

News
May 27, 2022
2 min read
Save

Hispanic children with high-risk neuroblastoma have worse survival outcomes

Hispanic children with high-risk neuroblastoma have worse survival outcomes

Hispanic children with high-risk neuroblastoma had worse survival outcomes than other children with the disease despite receiving treatment on clinical trials with standardized protocols, according to study results.

News
May 23, 2022
1 min read
Save

FDA approves azacitidine for pediatric leukemia indication

FDA approves azacitidine for pediatric leukemia indication

The FDA approved azacitidine for treatment of pediatric patients with newly diagnosed juvenile myelomonocytic leukemia.

News
May 21, 2022
1 min read
Save

Oncology Nursing Foundation announces mentorship award recipient

Oncology Nursing Foundation announces mentorship award recipient

Kathleen Shannon Dorcy, PhD, RN, FAAN, received this year’s Connie Henke Yarbro Excellence in Cancer Nursing Mentorship Award.

News
May 16, 2022
3 min read
Save

AYA survivors of leukemia have worse long-term survival outcomes than general population

AYA survivors of leukemia have worse long-term survival outcomes than general population

Survivors of adolescent and young-adult acute myeloid leukemia and acute lymphoblastic leukemia had lower long-term survival rates than the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.

News
May 09, 2022
3 min read
Save

CAR-associated hemophagocytic lymphohistiocytosis linked to poor outcomes in ALL

CAR-associated hemophagocytic lymphohistiocytosis linked to poor outcomes in ALL

Younger patients who developed treatment-related hemophagocytic lymphohistiocytosis after tisagenlecleucel infusion for relapsed or refractory B-cell acute lymphoblastic leukemia had significantly poorer outcomes, according to study results.

News
May 03, 2022
2 min read
Save

Fludarabine may improve outcomes in pediatric B-cell acute lymphoblastic leukemia

Fludarabine may improve outcomes in pediatric B-cell acute lymphoblastic leukemia

Fludarabine exposure appeared associated with improved clinical outcomes among pediatric patients undergoing chimeric antigen receptor T-cell therapy for refractory or relapsed B-cell acute lymphoblastic leukemia, study results showed.

News
April 25, 2022
3 min read
Save

Azithromycin timing, duration does not affect hematologic relapse after pediatric HSCT

Azithromycin timing, duration does not affect hematologic relapse after pediatric HSCT

SALT LAKE CITY — Early azithromycin use did not affect hematologic relapse among pediatric hematopoietic stem cell transplant recipients, according to study results.

News
April 25, 2022
2 min read
Save

Young survivors of acute leukemia at high risk for late mortality

Young survivors of acute leukemia at high risk for late mortality

SALT LAKE CITY — Pediatric and young adult survivors of acute leukemia who underwent allogeneic hematopoietic stem cell transplantation appeared to be at increased risk for late mortality, according to study results.

View more